Assay News and Research

RSS
Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

22 Apr 2022
COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

21 Apr 2022
Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

21 Apr 2022
Most blood tests to detect Alzheimer’s disease perform inconsistently across racial groups

Most blood tests to detect Alzheimer’s disease perform inconsistently across racial groups

21 Apr 2022
CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

21 Apr 2022
Association between SARS-CoV-2 Omicron viral load and vaccination history

Association between SARS-CoV-2 Omicron viral load and vaccination history

21 Apr 2022
Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

21 Apr 2022
Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

21 Apr 2022
Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

20 Apr 2022
Investigating the impact of SARS-CoV-2 Omicron spike mutations

Investigating the impact of SARS-CoV-2 Omicron spike mutations

20 Apr 2022
Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

20 Apr 2022
Waning antibody responses in SARS-CoV-2-infected children and adults over time

Waning antibody responses in SARS-CoV-2-infected children and adults over time

20 Apr 2022
Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

20 Apr 2022
Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

20 Apr 2022
Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

20 Apr 2022
New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

20 Apr 2022
New, longest documented case of persistent acute SARS-CoV-2 infection

New, longest documented case of persistent acute SARS-CoV-2 infection

18 Apr 2022
The brain's reaction to COVID's inflammatory tidal wave

The brain's reaction to COVID's inflammatory tidal wave

18 Apr 2022
Researchers develop and validate polygenic risk scores for six common diseases

Researchers develop and validate polygenic risk scores for six common diseases

18 Apr 2022
Study investigates the production of a virosome-based COVID-19 vaccine candidate

Study investigates the production of a virosome-based COVID-19 vaccine candidate

18 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback